HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

taizhi'an

has lipid-lowering activity

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        taizhi'an: 4
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - taizhi'an: 4

Experts

1.	Shan, Jian-Zhen: 1 article (04/2007)
2.	Sun, Mei: 1 article (04/2007)
3.	Ying, Hua-Zhong: 1 article (04/2007)
4.	Zhang, Guo-Ping: 1 article (04/2007)
5.	Gao, Feng: 1 article (03/2006)
6.	Hu, Xiu-fen: 1 article (03/2006)
7.	Cheng, Bei: 1 article (05/2004)
8.	Qi, Ben-ling: 1 article (05/2004)
9.	Zhang, Qiao-hong: 1 article (05/2004)
10.	Li, Qing-lang: 1 article (05/2003)

Related Diseases

1.	Fatty Liver 04/01/2007 - "[Experimental study on treating hyperlipidemic fatty liver with Taizhi'an capsule]." 04/01/2007 - "To observe the effects of Taizhi'an capsule in treatment of hyperlipidemic fatty liver. "
2.	Hyperlipidemias (Hyperlipidemia) 05/01/2003 - "[Clinical observation on effect of taizhi'an capsule in treating 150 patients with hyperlipidemia]." 03/01/2006 - "Effect of Taizhi'an capsule combined with Simvastatin on hyperlipidemia in diabetic patients." 03/01/2006 - "To evaluate the effectiveness and safety of Taizhi'an (TZA) capsule combined with Simvastatin (Sim) in treating hyperlipidemia in diabetes mellitus (DM) patients. " 05/01/2003 - "Three hundred patients with hyperlipidemia were randomly divided adopting numerical table method into 7 groups, the Taizhi'an group (A, n = 90), the half-dose Fenofibrate plus Taizhi'an group (B, n = 30), the full-dose Fenofibrate group (C, n = 30), the half-dose Simvastatin plus Taizhi'an group (D, n = 30), the full-dose Simvastatin group (E, n = 30), the Zhibituo group (F, n = 60) and the Xuezhikang group (G, n = 30). "
3.	Atherosclerosis 05/01/2004 - "To explore the anti-atherosclerosis effect of Taizhi'an Capsule (TZA) for providing a theoretical base of its application in preventing coronary heart disease (CHD), by way of observing the effects of TZA and pravastatin (PVT) on vascular endothelial function in senile patients with CHD. "
4.	Diabetes Mellitus 03/01/2006 - "To evaluate the effectiveness and safety of Taizhi'an (TZA) capsule combined with Simvastatin (Sim) in treating hyperlipidemia in diabetes mellitus (DM) patients. "
5.	Coronary Disease (Coronary Heart Disease) 05/01/2004 - "[Comparison of effects of taizhi' an capsule and pravastatin on vascular endothelial function in senile patients with coronary heart disease]." 05/01/2004 - "To explore the anti-atherosclerosis effect of Taizhi'an Capsule (TZA) for providing a theoretical base of its application in preventing coronary heart disease (CHD), by way of observing the effects of TZA and pravastatin (PVT) on vascular endothelial function in senile patients with CHD. "

Related Drugs and Biologics

1.	Capsules (Microcapsules)
2.	Simvastatin (Zocor)
3.	Pravastatin (Pravachol)
4.	Fenofibrate (CiL)
5.	xuezhikang
6.	N 30